Concepedia

Publication | Open Access

A New Advanced<scp>MRI</scp>Biomarker for Remyelinated Lesions in Multiple Sclerosis

80

Citations

55

References

2022

Year

Abstract

These results provide the first evidence that it is possible to distinguish chronic MS lesions in a clinical setting, hereby supporting with new biomarkers to develop and assess remyelinating treatments. ANN NEUROL 2022;92:486-502.

References

YearCitations

Page 1